PeraMobile and PeraWatch
by PeraHealth (acquired by Spacelabs Healthcare)
· Based in United States →
— Transforming healthcare through the intelligent use of data.
Contact for pricing
Regulatory Status Disclosed
Overview
PeraHealth, now part of Spacelabs Healthcare, develops predictive enterprise software solutions, PeraMobile and PeraWatch, powered by the Rothman Index. The Rothman Index is a statistically validated patient acuity score that quantifies a patient’s condition in real-time by leveraging existing data within a hospital’s Electronic Health Record (EHR), including vital signs, nursing assessments, and lab values.
These solutions are designed to provide continuous clinical surveillance, alerting clinicians to subtle changes in patient condition before they become critical. PeraMobile offers mobile access for on-the-go clinicians to track patient changes, while PeraWatch provides system-wide virtual surveillance for ‘command center’ clinicians. The technology aims to enable earlier intervention, improve quality of care, reduce in-hospital mortality rates, and prevent unplanned transfers to the ICU.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Real-time patient acuity scoring (Rothman Index)
- Predictive analytics for patient deterioration
- Integration with major EHR vendors
- Mobile access for on-the-go clinicians (PeraMobile)
- System-wide virtual surveillance (PeraWatch)
- Configurable warning states and push notifications
- Visual dashboards of patient condition trends (PeraTrend)
- Retrospective analytics for quality improvement (PeraAnalytics)
- Leverages vital signs, nursing assessments, and lab data
- Reduces in-hospital mortality and unplanned ICU transfers
Use Cases
- Early detection of patient deterioration
- Supporting Rapid Response Teams
- Reducing in-hospital mortality rates
- Preventing unplanned transfers to the ICU
- Improving palliative care consults
- Enhancing care efficiency and effectiveness
What Physicians Need to Know
Evidence Base
PeraMobile and PeraWatch are powered by the Rothman Index (RI), a clinically validated patient surveillance platform that uses commonly recorded vital sign, nursing assessment, and lab data to generate a single score representing a patient's physiological condition and associated statistical mortality risk. The Rothman Index is proven to reduce mortality in practice.
Clinical Validation Studies
The Rothman Index score has been validated for use across neonatal, pediatric, and adult patient populations. Software verification and validation testing for PeraMobile and PeraWatch was conducted in accordance with FDA guidance for software in medical devices. These tools are FDA-cleared as adjuncts to clinical decision support.
Alert Fatigue Management
PeraMobile offers configurable notification options, allowing clinicians to set parameters for push notifications to the clinical response team, which helps reduce alarm fatigue and build system trust. Both PeraWatch and PeraMobile provide notification lists for patients with new warnings, and PeraMobile can display pop-up notifications. PeraWatch utilizes color-coding to indicate changes in a patient's warning state over the last four hours, assisting in rapid identification of patient status changes, especially in large patient cohorts.
Clinical Workflow Integration
PeraMobile and PeraWatch integrate with Hospital Electronic Health Records (EHR) and other medical automation systems via PeraServer/PeraTrend. PeraMobile supports mobile clinicians by allowing documentation of pre-defined interventions and free-text notes directly within the application, which are then stored in PeraServer. PeraWatch is a web-based interface for broad patient surveillance, including across multiple facilities, while PeraMobile provides mobile access and out-of-app notifications for rapid response teams and proactive patient rounding.
Decision Audit Trail
PeraServer, which underpins PeraMobile and PeraWatch, stores input data, Rothman Index scores, and warning states for analysis and remote viewing, indicating a capability for tracking patient status changes and associated alerts.
Physician Tip
Leverage PeraMobile for proactive patient rounding and rapid response, utilizing its configurable notifications to minimize alert fatigue while staying informed of patient deterioration. For broader oversight, use PeraWatch's web-based interface to monitor large patient populations and identify trends. Remember that these tools are adjuncts to, not replacements for, comprehensive clinical assessment.
PeraMobile and PeraWatch seamlessly integrate with existing Electronic Health Record (EHR) systems and other hospital information systems through PeraServer/PeraTrend, facilitating real-time data flow and supporting a unified view of patient status within the clinical workflow.
Details
| Category | Clinical Decision Support & Reference, Population Health Analytics, Triage & ER/ICU AI |
| Pricing | Contact for pricing — Not publicly disclosed; enterprise-level solution |
| Deployment | Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated PeraMobile and PeraWatch System (K183370) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on September 11, 2019. It is classified as a Class II device (Cardiac Monitor, Product Code MWI) and is intended for use in hospitals to display and trend Rothman Index scores and configurable warning states as an adjunct to clinical decision support, supporting Rapid Response Team clinicians or other dedicated clinical response staff. |
| Integrations | |
| EHR | Not specified |
| Specialties | Critical Care, Emergency Medicine, Hospital Medicine |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate PeraMobile and PeraWatch
Press & Coverage
FDA
510(k) Premarket Notification - PeraMobile and PeraWatch
This regulatory announcement details the 510(k) Premarket Notification for PeraMobile and PeraWatch by Perahealth, Inc., classifying them as physiological patient monitors. The document outlines the indications for use, stating they are intended for healthcare professionals in a professional care setting to augment and support bedside clinicians by providing a second pair of eyes on evolving patient conditions.
2026-05
Spacelabs Healthcare
Spacelabs Healthcare Expands Clinical Informatics Capabilities with Acquisition of Predictive Analytics Company PeraHealth
Spacelabs Healthcare announced its acquisition of PeraHealth, a company specializing in predictive enterprise software based on the Rothman Index, an FDA-cleared solution for quantifying patient acuity. This acquisition aims to integrate PeraHealth's analytics into Spacelabs' digital health portfolio to improve patient outcomes and reduce costs.
2023-02
Research Live
Spacelabs acquires predictive analytics business | News - Research Live
Medical equipment manufacturer Spacelabs Healthcare acquired predictive analytics company PeraHealth, known for its Rothman Index-based software that alerts clinicians to patient deterioration. Joseph Beals, former CEO of PeraHealth, will now lead data science strategy at Spacelabs.
2023-03
Business Wire
Spacelabs Healthcare Announces Agreement to Provide its Rothman Indexu00ae to Hospitals and Health Systems Through DEPTH Health
Spacelabs Healthcare has partnered with DEPTH Health to integrate its Rothman Index, an advanced application for identifying subtle changes in patient conditions, into DEPTH's Real-Time Advisor for Clinical Expert Routing (RACERu2122) offering. This collaboration aims to help healthcare providers intervene proactively and improve patient care.
2026-04
Videos
Product demos, reviews, and walkthroughs for PeraMobile and PeraWatch.
Loading videos...
Frequently Asked Questions
PeraMobile and PeraWatch serve as adjuncts to clinical decision support, providing real-time display and trending of Rothman Index (RI) scores and configurable warning states for patients. PeraMobile is a mobile app for on-the-go clinicians and rapid response teams, while PeraWatch offers centralized or remote surveillance across hospital settings, enabling proactive decision-making.
As medical devices, PeraMobile and PeraWatch are subject to FDA regulations, including requirements for registration, listing, labeling, and medical device reporting. While specific data security protocols like HIPAA compliance are not explicitly detailed in the provided information, these are standard expectations for healthcare technologies handling sensitive patient data.
PeraMobile and PeraWatch uniquely leverage the Rothman Index (RI), a single measure derived from over 700 real-time data points like vital signs, nursing assessments, and lab results, to predict patient deterioration. Unlike general wearables, these systems are specifically designed for in-hospital clinical surveillance and decision support, augmenting existing care rather than replacing it.
The provided information does not detail the specific pricing or cost structure for PeraMobile and PeraWatch. Typically, such enterprise-level clinical decision support systems involve institutional licensing fees, implementation costs, and ongoing maintenance, which would require direct consultation with the vendor.
These tools are intended to augment, not replace, the usual care measures provided by primary or direct caregivers at the bedside. While they aim to reduce alarm fatigue through configurable notifications, physicians must remember that the systems are adjuncts and clinical judgment remains paramount.
The Rothman Index (RI) is an early warning system that assimilates disparate clinical data to provide a patient status index, with studies showing its effectiveness in predicting potential emergencies and improving outcomes. While specific training details aren't provided, its use as a clinical decision support tool implies that healthcare professionals would receive necessary instruction for accurate interpretation.
Yes, PeraMobile and PeraWatch are designed to integrate with existing hospital systems. The underlying PeraServer collects specified demographic and clinical data from the EHR and ancillary systems to compute the Rothman Index.
Compare PeraMobile and PeraWatch
VS
PeraMobile and PeraWatch vs SIS System
Tool A, PeraMobile and PeraWatch, offers broad, system-wide predictive analytics for general patient deterioration, aiding in earlier intervention across various patient populations. In contrast, the SIS System (Tool…
VS
PeraMobile and PeraWatch vs ContaCT
Tool A focuses on general patient deterioration and acuity scoring across the hospital using predictive analytics to identify at-risk patients. In contrast, Tool B specializes in AI-powered detection…
VS
PeraMobile and PeraWatch vs Viz CTP
Tool A focuses on predictive analytics for general patient deterioration using clinical data and acuity scoring to identify at-risk patients sooner. In contrast, Tool B specializes in AI-powered…
VS
PeraMobile and PeraWatch vs Viz HCM
Tool A offers a broad predictive analytics solution for general patient deterioration across various conditions, leveraging the Rothman Index for early intervention. In contrast, Tool B is a…
Suggest an Edit →
| Last Verified: 2026-04-18 | First Added: 2026-04-18